CURRENT HYPERTENSION REPORTS
Scope & Guideline
Transforming cardiovascular care through innovative research.
Introduction
Aims and Scopes
- Hypertension Pathophysiology:
Research exploring the biological and physiological mechanisms contributing to hypertension, including genetic, metabolic, and environmental factors. - Innovative Treatment Approaches:
Studies evaluating new pharmacological treatments, lifestyle interventions, and technological advancements aimed at managing hypertension and its complications. - Pediatric and Adolescent Hypertension:
Focus on the prevalence, causes, and management strategies for hypertension in children and adolescents, highlighting the long-term implications for cardiovascular health. - Hypertension in Special Populations:
Investigations into hypertension management among diverse populations, including pregnant women, individuals with chronic diseases, and racial/ethnic minorities. - Systematic Reviews and Meta-analyses:
Comprehensive reviews synthesizing existing literature on various hypertension-related topics, providing evidence-based guidance for clinicians. - Public Health and Policy Implications:
Research addressing hypertension as a public health issue, including studies on health disparities, access to care, and policy recommendations for improving hypertension management.
Trending and Emerging
- Machine Learning and Predictive Analytics:
An increasing number of studies are leveraging machine learning and predictive analytics to enhance the prediction and management of hypertension, indicating a shift towards data-driven approaches in healthcare. - Gut Microbiota and Hypertension:
Emerging research focusing on the relationship between gut microbiota and hypertension suggests novel pathways for understanding and treating hypertension through microbiome modulation. - Impact of Lifestyle Interventions:
There is a growing emphasis on the effects of lifestyle changes, such as diet and physical activity, particularly in resistant hypertension contexts, showcasing the importance of holistic treatment strategies. - Hypertension in the Context of Comorbidities:
Research increasingly explores hypertension's interplay with other conditions, such as diabetes, obesity, and COVID-19, reflecting a comprehensive approach to managing patients with multiple health issues. - Health Disparities and Inequities:
An emerging focus on the impact of social determinants of health and health inequities in hypertension management underscores the importance of addressing systemic barriers to care.
Declining or Waning
- Historical Perspectives on Hypertension:
While historical reviews provided valuable context, there has been a noticeable decline in papers that solely focus on the historical aspects of hypertension research, as the journal shifts towards contemporary issues. - Traditional Antihypertensive Medications:
There appears to be a reduction in studies centered on older antihypertensive medications, as newer therapeutic options and innovative treatments gain more attention. - Single-Factor Analysis of Hypertension:
Research focusing exclusively on single factors (e.g., diet or exercise alone) has decreased, with a growing emphasis on multifactorial approaches and comprehensive lifestyle interventions. - General Hypertension Education:
Papers that focus primarily on general education about hypertension without new research findings or innovative insights are becoming less common, as the journal prioritizes evidence-based research.
Similar Journals
CLINICAL AND EXPERIMENTAL HYPERTENSION
Uncovering breakthroughs in hypertension studies.Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.
Hypertension Research in Pregnancy
Empowering clinicians with cutting-edge insights on pregnancy hypertension.Hypertension Research in Pregnancy is a specialized journal dedicated to advancing the understanding of hypertension during pregnancy, an area critical for both maternal and fetal health. Published by the Japan Society for the Study of Hypertension in Pregnancy, this journal serves as a platform for researchers, clinicians, and healthcare professionals who are committed to improving outcomes in this vital field. Although currently not an open-access publication, Hypertension Research in Pregnancy disseminates rigorous scientific research and reviews that forge a path for innovative therapeutic strategies and clinical practices. With an emphasis on the latest findings and methodological advancements, the journal aims to address key challenges and promote best practices in care for hypertensive disorders in pregnancy. As a repository of knowledge and a catalyst for collaboration, it plays a crucial role in shaping future research directions and clinical interventions, making it an essential resource for anyone involved in obstetric care and maternal-fetal medicine.
International Journal of Hypertension
Connecting knowledge and practice in hypertension care.The International Journal of Hypertension, published by HINDAWI LTD, is a pivotal open-access journal dedicated to advancing knowledge in the field of hypertension and cardiovascular health. Since its inception in 2010, the journal has provided a vital platform for researchers, clinicians, and students to disseminate innovative findings and comprehensive reviews spanning various aspects of hypertension management, pathophysiology, and epidemiology. Residing in Q3 of the Internal Medicine category and ranked 75 out of 167 in the Scopus rankings, it reflects a commitment to quality and relevance in medical research. With a global reach, the journal aims to foster collaboration and knowledge exchange, contributing significantly to the scientific community's efforts to combat hypertension-related health issues. Accessible since 2010, this journal exemplifies the principles of open science, ensuring that critical research is available to all stakeholders in the field.
HYPERTENSION
Advancing knowledge in cardiovascular health.HYPERTENSION, published by Lippincott Williams & Wilkins, is a preeminent journal in the field of cardiovascular medicine, focusing on the latest research, therapies, and clinical practices related to hypertension and its associated disorders. With a distinguished Q1 ranking in Internal Medicine and a commendable Scopus rank of #12 out of 167 in its category, it occupies a vital position within the academic community, appealing to researchers, clinicians, and educators alike. The journal has been disseminating impactful findings since 1979 and continues to influence the discourse on hypertension through rigorous peer-reviewed articles, reviews, and studies designed to elevate understanding and treatment of this prevalent condition. HYPERTENSION remains an essential resource for professionals keen on advancing their knowledge in this critical area of medicine, fostering innovations that ultimately improve patient care.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Driving discoveries in circulatory health and disease.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, published by the American Physiological Society, is a premier journal dedicated to advancing the understanding of cardiovascular physiology. With an ISSN of 0363-6135 and an E-ISSN of 1522-1539, this esteemed journal has been a vital resource since its inception in 1977, and continues to publish cutting-edge research that shapes the fields of cardiology and physiology. Recognized as a Q1 journal in multiple categories, it ranks impressively within the top tier of its fields, including a notable 18th percentile rank in Physiology (medical). The journal’s impact factor and extensive reach in the academic community affirm its significance in promoting innovative studies and insights. While it does not offer open access options, the journal remains accessible through institutional subscriptions, making it an essential tool for researchers, professionals, and students alike, who are keen to stay abreast of the latest developments in heart and circulatory physiology. For further information, the journal is based in the United States at 6120 Executive Blvd, Suite 600, Rockville, MD 20852. As a cornerstone of cardiovascular research, it invites contributions that push the boundaries of knowledge and enhance clinical practice.
Current Hypertension Reviews
Elevating Standards in Hypertension CareCurrent Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.
KIDNEY & BLOOD PRESSURE RESEARCH
Pioneering Research for a Healthier Tomorrow.Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.
Minerva Cardiology and Angiology
Exploring the frontiers of cardiology and vascular science.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
Clinical Hypertension
Pioneering open access in cardiovascular research.Clinical Hypertension is a premier journal dedicated to advancing the field of hypertension and cardiovascular health, published by SpringerNature. Since its transition to an Open Access model in 2014, the journal has opened doors for researchers globally to share their findings without barriers, aiming to foster collaboration and innovation in this vital area of medicine. With a current impact factor that positions it in the Q2 quartile for both Cardiology and Cardiovascular Medicine and Internal Medicine, Clinical Hypertension is recognized for its scholarly contributions, reflected in its Scopus rankings (Rank #100/387 in Cardiology and Rank #52/167 in Internal Medicine), which place it in the top percentiles of these competitive fields. Covering a diverse range of topics within hypertension research, it serves as an essential resource for clinicians, researchers, and students alike, promising to keep its audience informed of the latest developments and breakthroughs from its inception in 2017 through to 2024.
HEART & LUNG
Exploring the Frontiers of Cardiovascular and Respiratory MedicineHEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.